Logo image of ALS.CA

ALTIUS MINERALS CORPORATION (ALS.CA) Stock Fundamental Analysis

TSX:ALS - Toronto Stock Exchange - CA0209361009 - Common Stock - Currency: CAD

27.43  +0.3 (+1.11%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ALS. ALS was compared to 832 industry peers in the Metals & Mining industry. ALS scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ALS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

ALS had positive earnings in the past year.
In the past year ALS had a positive cash flow from operations.
Of the past 5 years ALS 4 years were profitable.
ALS had a positive operating cash flow in each of the past 5 years.
ALS.CA Yearly Net Income VS EBIT VS OCF VS FCFALS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.73%, ALS belongs to the top of the industry, outperforming 87.68% of the companies in the same industry.
ALS's Return On Equity of 2.72% is amongst the best of the industry. ALS outperforms 87.82% of its industry peers.
With an excellent Return On Invested Capital value of 2.68%, ALS belongs to the best of the industry, outperforming 89.56% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ALS is significantly below the industry average of 11.94%.
Industry RankSector Rank
ROA 1.73%
ROE 2.72%
ROIC 2.68%
ROA(3y)3.86%
ROA(5y)2.02%
ROE(3y)6.3%
ROE(5y)3.2%
ROIC(3y)4.14%
ROIC(5y)3.84%
ALS.CA Yearly ROA, ROE, ROICALS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 -10 -15 -20

1.3 Margins

Looking at the Profit Margin, with a value of 22.75%, ALS belongs to the top of the industry, outperforming 96.92% of the companies in the same industry.
In the last couple of years the Profit Margin of ALS has grown nicely.
ALS has a better Operating Margin (48.57%) than 98.66% of its industry peers.
In the last couple of years the Operating Margin of ALS has grown nicely.
The Gross Margin of ALS (89.63%) is better than 99.46% of its industry peers.
In the last couple of years the Gross Margin of ALS has remained more or less at the same level.
Industry RankSector Rank
OM 48.57%
PM (TTM) 22.75%
GM 89.63%
OM growth 3Y4.48%
OM growth 5Y18.53%
PM growth 3YN/A
PM growth 5Y39.24%
GM growth 3Y0.09%
GM growth 5Y0.56%
ALS.CA Yearly Profit, Operating, Gross MarginsALS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800 -1K

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALS is destroying value.
The number of shares outstanding for ALS has been reduced compared to 1 year ago.
Compared to 5 years ago, ALS has more shares outstanding
The debt/assets ratio for ALS has been reduced compared to a year ago.
ALS.CA Yearly Shares OutstandingALS.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
ALS.CA Yearly Total Debt VS Total AssetsALS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

An Altman-Z score of 3.01 indicates that ALS is not in any danger for bankruptcy at the moment.
ALS has a better Altman-Z score (3.01) than 60.24% of its industry peers.
The Debt to FCF ratio of ALS is 3.46, which is a good value as it means it would take ALS, 3.46 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 3.46, ALS belongs to the best of the industry, outperforming 91.97% of the companies in the same industry.
A Debt/Equity ratio of 0.19 indicates that ALS is not too dependend on debt financing.
The Debt to Equity ratio of ALS (0.19) is worse than 72.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 3.46
Altman-Z 3.01
ROIC/WACC0.28
WACC9.64%
ALS.CA Yearly LT Debt VS Equity VS FCFALS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 8.36 indicates that ALS has no problem at all paying its short term obligations.
ALS has a Current ratio of 8.36. This is amongst the best in the industry. ALS outperforms 82.60% of its industry peers.
ALS has a Quick Ratio of 8.36. This indicates that ALS is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 8.36, ALS belongs to the best of the industry, outperforming 82.60% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.36
Quick Ratio 8.36
ALS.CA Yearly Current Assets VS Current LiabilitesALS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M

3

3. Growth

3.1 Past

The earnings per share for ALS have decreased by -3.57% in the last year.
The Earnings Per Share has been growing by 45.74% on average over the past years. This is a very strong growth
The Revenue for ALS has decreased by -21.53% in the past year. This is quite bad
ALS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.98% yearly.
EPS 1Y (TTM)-3.57%
EPS 3Y1.43%
EPS 5Y45.74%
EPS Q2Q%0%
Revenue 1Y (TTM)-21.53%
Revenue growth 3Y4.69%
Revenue growth 5Y6.98%
Sales Q2Q%-13.91%

3.2 Future

The Earnings Per Share is expected to grow by 16.63% on average over the next years. This is quite good.
The Revenue is expected to decrease by -1.28% on average over the next years.
EPS Next Y19.64%
EPS Next 2Y25.26%
EPS Next 3Y23.49%
EPS Next 5Y16.63%
Revenue Next Year-9.02%
Revenue Next 2Y-4.21%
Revenue Next 3Y-4.49%
Revenue Next 5Y-1.28%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALS.CA Yearly Revenue VS EstimatesALS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M 100M
ALS.CA Yearly EPS VS EstimatesALS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 101.59 indicates a quite expensive valuation of ALS.
Compared to the rest of the industry, the Price/Earnings ratio of ALS indicates a rather cheap valuation: ALS is cheaper than 85.81% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.36, ALS is valued quite expensively.
The Price/Forward Earnings ratio is 72.84, which means the current valuation is very expensive for ALS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALS indicates a rather cheap valuation: ALS is cheaper than 86.35% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 92.49. ALS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 101.59
Fwd PE 72.84
ALS.CA Price Earnings VS Forward Price EarningsALS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALS is valued cheaper than 87.42% of the companies in the same industry.
91.43% of the companies in the same industry are more expensive than ALS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 41.51
EV/EBITDA 33.92
ALS.CA Per share dataALS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of ALS may justify a higher PE ratio.
ALS's earnings are expected to grow with 23.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.17
PEG (5Y)2.22
EPS Next 2Y25.26%
EPS Next 3Y23.49%

5

5. Dividend

5.1 Amount

ALS has a Yearly Dividend Yield of 1.33%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 7.68, ALS pays a better dividend. On top of this ALS pays more dividend than 95.98% of the companies listed in the same industry.
With a Dividend Yield of 1.33, ALS pays less dividend than the S&P500 average, which is at 2.28.
Industry RankSector Rank
Dividend Yield 1.33%

5.2 History

The dividend of ALS has a limited annual growth rate of 1.91%.
ALS has been paying a dividend for at least 10 years, so it has a reliable track record.
ALS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)1.91%
Div Incr Years4
Div Non Decr Years4
ALS.CA Yearly Dividends per shareALS.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

ALS pays out 108.18% of its income as dividend. This is not a sustainable payout ratio.
The dividend of ALS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP108.18%
EPS Next 2Y25.26%
EPS Next 3Y23.49%
ALS.CA Yearly Income VS Free CF VS DividendALS.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M -60M
ALS.CA Dividend Payout.ALS.CA Dividend Payout, showing the Payout Ratio.ALS.CA Dividend Payout.PayoutRetained Earnings

ALTIUS MINERALS CORPORATION

TSX:ALS (2/3/2025, 7:00:00 PM)

27.43

+0.3 (+1.11%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners24.64%
Inst Owner ChangeN/A
Ins Owners5.32%
Ins Owner ChangeN/A
Market Cap1.27B
Analysts78.18
Price Target31.69 (15.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.33%
Yearly Dividend0.3
Dividend Growth(5Y)1.91%
DP108.18%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-21.32%
Min EPS beat(2)-29.28%
Max EPS beat(2)-13.37%
EPS beat(4)1
Avg EPS beat(4)-9.83%
Min EPS beat(4)-29.28%
Max EPS beat(4)6.63%
EPS beat(8)1
Avg EPS beat(8)-29.98%
EPS beat(12)1
Avg EPS beat(12)-21.95%
EPS beat(16)4
Avg EPS beat(16)-2.43%
Revenue beat(2)1
Avg Revenue beat(2)-1.93%
Min Revenue beat(2)-15.78%
Max Revenue beat(2)11.92%
Revenue beat(4)2
Avg Revenue beat(4)-4.87%
Min Revenue beat(4)-17.16%
Max Revenue beat(4)11.92%
Revenue beat(8)3
Avg Revenue beat(8)-6.09%
Revenue beat(12)5
Avg Revenue beat(12)-3.15%
Revenue beat(16)5
Avg Revenue beat(16)-3.4%
PT rev (1m)4.32%
PT rev (3m)8.21%
EPS NQ rev (1m)9.53%
EPS NQ rev (3m)-4.16%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-32.18%
Revenue NY rev (1m)-0.22%
Revenue NY rev (3m)-4.27%
Valuation
Industry RankSector Rank
PE 101.59
Fwd PE 72.84
P/S 21.11
P/FCF 41.51
P/OCF 39.29
P/B 2.53
P/tB 2.53
EV/EBITDA 33.92
EPS(TTM)0.27
EY0.98%
EPS(NY)0.38
Fwd EY1.37%
FCF(TTM)0.66
FCFY2.41%
OCF(TTM)0.7
OCFY2.55%
SpS1.3
BVpS10.85
TBVpS10.85
PEG (NY)5.17
PEG (5Y)2.22
Profitability
Industry RankSector Rank
ROA 1.73%
ROE 2.72%
ROCE 3.77%
ROIC 2.68%
ROICexc 3.12%
ROICexgc 3.12%
OM 48.57%
PM (TTM) 22.75%
GM 89.63%
FCFM 50.86%
ROA(3y)3.86%
ROA(5y)2.02%
ROE(3y)6.3%
ROE(5y)3.2%
ROIC(3y)4.14%
ROIC(5y)3.84%
ROICexc(3y)4.79%
ROICexc(5y)4.28%
ROICexgc(3y)4.79%
ROICexgc(5y)4.3%
ROCE(3y)5.83%
ROCE(5y)5.4%
ROICexcg growth 3Y3.26%
ROICexcg growth 5Y20.82%
ROICexc growth 3Y3.64%
ROICexc growth 5Y21.12%
OM growth 3Y4.48%
OM growth 5Y18.53%
PM growth 3YN/A
PM growth 5Y39.24%
GM growth 3Y0.09%
GM growth 5Y0.56%
F-Score6
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 3.46
Debt/EBITDA 2.66
Cap/Depr 22.96%
Cap/Sales 2.88%
Interest Coverage 3.49
Cash Conversion 87.92%
Profit Quality 223.61%
Current Ratio 8.36
Quick Ratio 8.36
Altman-Z 3.01
F-Score6
WACC9.64%
ROIC/WACC0.28
Cap/Depr(3y)8.25%
Cap/Depr(5y)28.67%
Cap/Sales(3y)2.02%
Cap/Sales(5y)7.41%
Profit Quality(3y)224.69%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.57%
EPS 3Y1.43%
EPS 5Y45.74%
EPS Q2Q%0%
EPS Next Y19.64%
EPS Next 2Y25.26%
EPS Next 3Y23.49%
EPS Next 5Y16.63%
Revenue 1Y (TTM)-21.53%
Revenue growth 3Y4.69%
Revenue growth 5Y6.98%
Sales Q2Q%-13.91%
Revenue Next Year-9.02%
Revenue Next 2Y-4.21%
Revenue Next 3Y-4.49%
Revenue Next 5Y-1.28%
EBIT growth 1Y-17.41%
EBIT growth 3Y9.38%
EBIT growth 5Y26.8%
EBIT Next Year68.09%
EBIT Next 3Y24.41%
EBIT Next 5Y13.79%
FCF growth 1Y-54.92%
FCF growth 3Y0.81%
FCF growth 5Y37.2%
OCF growth 1Y-53.93%
OCF growth 3Y-0.55%
OCF growth 5Y18.87%